(Q45218456)

English

HLA-A31 strongly associates with carbamazepine-induced adverse drug reactions but not with carbamazepine-induced lymphocyte proliferation in a Japanese population

scientific article published on 29 December 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 December 2017

HLA-A31 strongly associates with carbamazepine-induced adverse drug reactions but not with carbamazepine-induced lymphocyte proliferation in a Japanese population (English)

1 reference

Europe PubMed Central

10 December 2017

author name string

Hiroyuki Niihara

1

1 reference

Europe PubMed Central

10 December 2017

Takeyasu Kakamu

2

1 reference

Europe PubMed Central

10 December 2017

Yasuyuki Fujita

3

1 reference

Europe PubMed Central

10 December 2017

Sakae Kaneko

4

1 reference

Europe PubMed Central

10 December 2017

Eishin Morita

5

1 reference

Europe PubMed Central

10 December 2017

publication date

29 December 2011

1 reference

Europe PubMed Central

10 December 2017

The Journal of Dermatology

1 reference

Europe PubMed Central

10 December 2017

39

1 reference

Europe PubMed Central

10 December 2017

594-601

1 reference

Europe PubMed Central

10 December 2017

7

1 reference

Europe PubMed Central

10 December 2017

Medical genetics: a marker for Stevens-Johnson syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

HLA-B locus in Caucasian patients with carbamazepine hypersensitivity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

HLA class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

HLA-DRB1 DNA sequencing based typing: an approach suitable for high throughput typing including unrelated bone marrow registry donors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

The lymphocyte transformation test in the diagnosis of drug hypersensitivity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

Drug eruption caused by azathioprine: value of using the drug-induced lymphocytes stimulation test for diagnosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

Drug-induced hypersensitivity syndrome associated with cytomegalovirus reactivation: immunological characterization of pathogenic T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

Association of the B-cell alloantigen DRw4 with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

Disease associations of the Ia-like human alloantigens. Contrasting patterns in rheumatoid arthritis and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

Re-evaluation of heterogeneity in HLA-B*510101 associated with Behçet's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2011.01457.X

21 January 2018

Identifiers

10.1111/J.1346-8138.2011.01457.X

1 reference

Europe PubMed Central

10 December 2017

1 reference

Europe PubMed Central

10 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45218456&oldid=2070407731"